Home/Filings/4/0000899243-21-002399
4//SEC Filing

Pandite Arundathy N. 4

Accession 0000899243-21-002399

CIK 0001680367other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 7:50 PM ET

Size

7.0 KB

Accession

0000899243-21-002399

Insider Transaction Report

Form 4
Period: 2021-01-05
Pandite Arundathy N.
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-01-05$0.01/sh+1,604$16101,907 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-01-051,6044,259 total
    Exercise: $0.01Exp: 2027-12-21Common Stock (1,604 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 5,863 shares of the Issuer's common stock and will vest in equal monthly installments through July 24, 2021, subject to the Reporting Person's continued service to the Issuer.

Issuer

Shattuck Labs, Inc.

CIK 0001680367

Entity typeother

Related Parties

1
  • filerCIK 0001827232

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 7:50 PM ET
Size
7.0 KB